Pulse Biosciences, Inc. (PLSE) Stock

Healthcare · Medical Instruments & Supplies · Member of Other US Stocks

Pulse Biosciences, Inc. (PLSE) closed at USD 46.32 on 2026-10-14, a change of +167 % over the past year, with a market capitalization of USD 3.25B.

Pulse Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Pulse Biosciences, Inc. key figures

Previous close

USD 46.32 (2026-10-14)

1-year change

+167 %

Market cap

USD 3.25B

Enterprise value

USD 3.16B

P/E ratio (trailing)

-41.07

P/E ratio (forward)

-38.97

EPS (trailing)

-1.11

EPS (forward)

-1.17

PEG ratio

n/a

Price to book

32.45

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.70

Employees

116

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Pulse Biosciences, Inc. and compare it with other stocks.